𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effect of estradiol upon serum enzymes in primary biliary cirrhosis

✍ Scribed by Joseph M. Guattery; William W. Faloon


Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
556 KB
Volume
7
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Biliary bile acids in primary biliary ci
✍ Burton Combes; Robert L. Carithers Jr.; Willis C. Maddrey; Santiago Munoz; Guada πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 92 KB πŸ‘ 1 views

Bile acid composition in fasting duodenal bile was assessed at entry and at 2 years in patients with primary biliary cirrhosis (PBC) enrolled in a randomized, doubleblind, placebo-controlled trial of ursodeoxycholic acid (UDCA) (10-12 mg/kg/d) taken as a single bedtime dose. Specimens were analyzed

Analysis of serum cytokine levels in pri
✍ Masayoshi Yamashiki; Yoshitane Kosaka; Akira Nishimura; Shozo Watanabe; Minoru N πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 102 KB πŸ‘ 2 views

By using commercially available ELISA kits, serum IL-6 and TNF-Ξ± levels in healthy adults, and the levels of various cytokines in patients with primary biliary cirrhosis or chronic viral liver diseases, were investigated. IL-6 levels of healthy subjects were distributed in a wide range, and the dist

Prediction of clinical outcomes in prima
✍ Marlyn J. Mayo; Julie Parkes; Beverley Adams-Huet; Burton Combes; A. S. Mills; R πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 241 KB πŸ‘ 1 views

Primary biliary cirrhosis (PBC) is sometimes diagnosed based on a positive antimitochondrial antibody in the appropriate clinical setting without a liver biopsy. Although a liver biopsy can assess the extent of liver fibrosis and provide prognostic information, serum fibrosis markers avoid biopsy co

Cholesterol-lowering effect of ursodeoxy
✍ RenΓ©e E. Poupon; Khadija Ouguerram; Yves ChrΓ©tien; Claudine Verneau; Eveline Esc πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 591 KB

We have previously shown in a 2-yr controlled trial that hypercholesterolemia, frequent in primary biliary cirrhosis, is lowered by ursodeoxycholic acid (13 to 15 mg daily). To further investigate this effect, we analyzed the influence of long-term ursodeoxycholic acid administration on serum lipids